Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2020

Dec 3, 2020

33625_dirs_2020-12-02_f65a45ad-e1c6-495f-9a36-e66a4248b84a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2020-12-01

Reporting Person: Bauerlein Alison (EVP, Finance, & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-01 Common Stock A 253 $35.28 Acquired 32815 Direct
2020-12-01 Common Stock F 126 $35.28 Disposed 32689 Direct
2020-12-01 Common Stock F 102 $35.28 Disposed 32587 Direct
2020-12-01 Common Stock F 117 $35.28 Disposed 32470 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-01 Restricted Stock Unit $ M 253 Acquired Common Stock (253) Direct

Footnotes

F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020.

F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3: 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months
thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date.